UK consumers reduced their purchases of food and alcohol during the recent holiday season, a trend attributed by industry experts to the increasing popularity of weight loss injections.
According to market research firm NielsenIQ, grocery sales reached £19.6 billion in the four weeks leading up to December 27, reflecting a 2.5% increase from the previous year. However, sales in terms of volume experienced a slight decline of 0.2%.
Analysts in the retail sector point to the growing use of GLP-1 injections, which simulate a key hormone to induce a quicker feeling of fullness in the body, as the driving force behind the correlation.
These injections, including Mounjaro and Wegovy for weight loss and Ozempic for diabetes, are prescribed by the NHS. Recent data from University College London suggests that approximately 1.6 million adults in the UK have utilized these injections in the past year.
Jonathan De Mello, a retail expert at JDM Retail, noted that the impact of Ozempic on grocery trends is evident, with a notable increase in GLP-1 usage leading to a year-on-year decrease in grocery volume among users.
Consumer analyst Clive Black from Shore Capital highlighted that the decline in grocery volume sales over the Christmas period may be directly linked to the influence of GLP drugs on eating habits nationwide.
Major retailers have responded by introducing smaller meal options at the start of the New Year. For instance, Co-op has launched a range of “mini meals” catering to individuals with smaller appetites, while Marks & Spencer and Iceland have rolled out nutrient-dense and expanded frozen meal selections, respectively.
Business leaders in the retail sector have acknowledged the impact of weight loss injections on consumer behavior. Greggs’ CEO acknowledged a shift towards smaller portions and a demand for specific nutritional information among customers, while Tesco’s CEO emphasized closely monitoring consumer trends amidst the rise in weight loss medication usage.
Sainsbury’s CEO echoed a similar sentiment, stating that the company is attentively observing changes in shopper habits. The industry as a whole is adapting to accommodate the evolving preferences of consumers influenced by weight loss medications.